Sapna Makhija
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Drug Solubulity and Delivery Systems, Analytical Chemistry and Chromatography, Analytical Methods in Pharmaceuticals, Nutrition and Health in Aging
Most-Cited Works
- → Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as a semipermeable membrane(2003)129 cited
- → The Subjective Global Assessment: A Review of Its Use in Clinical Practice(2008)107 cited
- → Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor(2016)105 cited
- → Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors(2012)99 cited
- → Stability indicating HPTLC method for the simultaneous determination of pseudoephedrine and cetirizine in pharmaceutical formulations(2001)89 cited
- → Once daily sustained release tablets of venlafaxine, a novel antidepressant(2002)57 cited
- → Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations(2002)42 cited
- → Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms(2025)5 cited
- → Abstract A230: Discovery and characterization of ARQ 092, an ATP-independent, potent and selective inhibitor of AKT kinases.(2011)4 cited
- Pharmacokinetics of a novel PGA-ARQ 501 conjugate in mouse xenografts(2007)